Quick Answer
Lipocine Inc. reported Research And Development Expense of $8.58 million for the year ending 2025.
- Lipocine Inc. showed an increase of +16.8% in Research And Development Expense from 2024 to 2025.
- This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $547.8 thousand | Q1 2013: $645.1 thousand | Q2 2013: $443.9 thousand | Q3 2013: $1.57 million | Q1 2014: $3.37 million | Q2 2014: $5.97 million | Q3 2014: $3.25 million | Q1 2015: $1.92 million | Q2 2015: $3.16 million | Q3 2015: $4.73 million | Q1 2016: $2.67 million | Q2 2016: $2.57 million | Q3 2016: $1.51 million | Q1 2017: $3.08 million | Q2 2017: $4.11 million | Q3 2017: $2.05 million | Q1 2018: $1.38 million | Q2 2018: $1.48 million | Q3 2018: $1.42 million | Q1 2019: $1.95 million | Q2 2019: $1.96 million | Q3 2019: $1.71 million | Q1 2020: $2.51 million | Q2 2020: $2.27 million | Q3 2020: $2.49 million | Q1 2021: $1.58 million | Q2 2021: $1.46 million | Q3 2021: $2.37 million | Q1 2022: $1.89 million | Q2 2022: $2.90 million | Q3 2022: $2.10 million | Q1 2023: $3.11 million | Q2 2023: $2.52 million | Q3 2023: $2.88 million | Q1 2024: $2.82 million | Q2 2024: $1.87 million | Q3 2024: $1.59 million | Q1 2025: $1.06 million | Q2 2025: $2.14 million | Q3 2025: $2.71 million.
- Over the full 14 years of available data (2012 to 2025), Lipocine Inc.'s Research And Development Expense has grown by 276.3%.
- Historical annual values: Fiscal year 2025: $8.58 million | Fiscal year 2024: $7.35 million | Fiscal year 2023: $10.18 million | Fiscal year 2022: $8.56 million | Fiscal year 2021: $7.67 million | Fiscal year 2020: $9.75 million | Fiscal year 2019: $7.47 million | Fiscal year 2018: $6.46 million | Fiscal year 2017: $11.00 million | Fiscal year 2016: $8.08 million | Fiscal year 2015: $12.58 million | Fiscal year 2014: $15.48 million | Fiscal year 2013: $5.12 million | Fiscal year 2012: $2.28 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: